Lab data suggests new COVID booster will protect against worrisome variant

“It is reassuring,” says Dr. Dan Barouch, who conducted one of the studies at the Beth Israel Deaconess Medical Center in Boston.

When it was first spotted, BA.2.86 set off alarm bells. It contains more than 30 mutations on the spike protein the virus uses to infect cells. That’s a level of mutation on par with the original Omicron variant, which caused a massive surge.

Read Full Article

US lab tests suggest new Covid-19 variant BA.2.86 may be less contagious and less immune-evasive than feared

“Two independent labs have basically shown that BA.2.86 essentially is not a further immune escape compared with current variants,” Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and leader of one of the labs, told CNN.

Read Full Article

CVVR Annual Faculty Dinner

NPR

U.S. Moves Closer To Biden’s July 4 COVID-19 Vaccination Goal

U.S. COVID-19 cases have dropped 95% since January. At least 65% of adults have had a least one vaccine shot. President Biden aims to have 70% of adults vaccinated with at least one shot by July 4. See Article

 

 

Unfortunately, there are no actively enrolling trials at this time.

A blood test showing the effectiveness of a vaccine on monkeys has the potential to speed up trials

A new study in monkeys suggests that a blood test could predict the effectiveness of a coronavirus vaccine — and perhaps speed up the clinical trials needed to get a working vaccine to billions of people around the world. Read Article

 

The Search for a Vaccine in the Age of COVID-19

A New Entry in the Race for a Coronavirus Vaccine: Hope

Scientists are increasingly optimistic that a vaccine can be produced in record time. But getting it manufactured and distributed will pose huge challenges. Read Article

axios

The race to make vaccines faster

In the race to create a vaccine for the novel coronavirus, some researchers are testing new approaches they hope can ultimately produce vaccines in months rather than years. Read Article